Regenerative medicine, resource and regulation: lessons learned from the remedi project

The successful commercialization of regenerative medicine products provides a unique challenge to the manufacturer owing to a lack of suitable investment/business models and a constantly evolving regulatory framework. The resultant slow translation of scientific discovery into safe and clinically ef...

Full description

Bibliographic Details

Main Authors:	Patrick J. Ginty, Erin Rayment, Paul Hourd, David Williams
Format:	Default Article
Published:	2011
Subjects:	Mechanical engineering not elsewhere classified Adoption Cell therapy Good manufacturing practice Investment Medical devices Regenerative medicine Regulation Reimbursement Value proposition Venture capital Mechanical Engineering not elsewhere classified
Online Access:	https://hdl.handle.net/2134/13379
Tags:	Add Tag No Tags, Be the first to tag this record!